XML 52 R37.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Segments of Business | 12 Months Ended
--- | ---
Mar. 31, 2017
Segment Reporting [Abstract] |
Segments of Business | Segments of Business We report our operations in two operating segments: McKesson Distribution Solutions and McKesson Technology Solutions. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. We evaluate the performance of our operating segments on a number of measures, including operating profit before interest expense, income taxes and results from discontinued operations. Our Distribution Solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and clinical trial access to our network of oncology physicians. It also provides medical-surgical supply distribution, logistics and other services to healthcare providers within the United States. Additionally, this segment operates retail pharmacy chains in Europe and Canada, and supports independent pharmacy networks within North America and Europe. It also supplies integrated pharmacy management systems, automated dispensing systems and related services to retail, outpatient, central fill, specialty and mail order pharmacies. On March 1, 2017, upon the closing of Healthcare Technology Net Asset Exchange, we contributed the majority of our McKesson Technology Solutions businesses to the newly formed joint venture, Change Healthcare. We retained our RelayHealth Pharmacy and EIS businesses. Accordingly, beginning March 31, 2017, Technology Solutions segment provides clinical, financial and supply chain management solutions to healthcare organizations and includes our equity method investment in Change Healthcare. Prior to March 1, 2017, this segment also delivered enterprise-wide clinical, patient care and strategic management technology solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. Refer to Financial Note 2, “Healthcare Technology Net Asset Exchange” for additional information about Change Healthcare. Corporate includes expenses associated with Corporate functions and projects, and the results of certain investments. Corporate expenses are allocated to operating segments to the extent that these items are directly attributable. Financial information relating to our reportable operating segments and reconciliations to the consolidated totals is as follows:
| Years Ended March 31,
(In millions) | 2017 |  | 2016 |  | 2015
Revenues |  |  |  |  |
Distribution Solutions (1) |  |  |  |  |
North America pharmaceutical distribution and services | $ | 164,832 |  |  | $ | 158,469 |  |  | $ | 143,711 |
International pharmaceutical distribution and services | 24,847 |  |  | 23,497 |  |  | 26,358 |
Medical-Surgical distribution and services | 6,244 |  |  | 6,033 |  |  | 5,907 |
Total Distribution Solutions | 195,923 |  |  | 187,999 |  |  | 175,976 |
Technology Solutions - products and services | 2,610 |  |  | 2,885 |  |  | 3,069 |
Total Revenues | $ | 198,533 |  |  | $ | 190,884 |  |  | $ | 179,045 |
Operating profit |  |  |  |  |
Distribution Solutions (2) (5) | $ | 3,361 |  |  | $ | 3,553 |  |  | $ | 3,047 |
Technology Solutions (3) (4) (5) | 4,215 |  |  | $ | 519 |  |  | $ | 438 |
Total | 7,576 |  |  | 4,072 |  |  | 3,485 |
Corporate Expenses, Net (5) | (377 | ) |  | $ | (469 | ) |  | $ | (454 | )
Interest Expense | (308 | ) |  | $ | (353 | ) |  | $ | (374 | )
Income From Continuing Operations Before Income Taxes | $ | 6,891 |  |  | $ | 3,250 |  |  | $ | 2,657 |
Depreciation and amortization (6) |  |  |  |  |
Distribution Solutions | $ | 735 |  |  | $ | 669 |  |  | $ | 750 |
Technology Solutions | 65 |  |  | 107 |  |  | 156 |
Corporate | 110 |  |  | 109 |  |  | 111 |
Total | $ | 910 |  |  | $ | 885 |  |  | $ | 1,017 |
Expenditures for long-lived assets (7) |  |  |  |  |
Distribution Solutions | $ | 276 |  |  | $ | 306 |  |  | $ | 301 |
Technology Solutions | 30 |  |  | 15 |  |  | 27 |
Corporate | 98 |  |  | 167 |  |  | 48 |
Total | $ | 404 |  |  | $ | 488 |  |  | $ | 376 |
Revenues, net by geographic area (8) |  |  |  |  |
United States | $ | 164,428 |  |  | $ | 158,255 |  |  | $ | 142,810 |
Foreign | 34,105 |  |  | 32,629 |  |  | 36,235 |
Total | $ | 198,533 |  |  | $ | 190,884 |  |  | $ | 179,045 |
(1) | Revenues derived from services represent less than 2% of this segment’s total revenues.
(2) | Distribution Solutions segment operating profit for 2016 includes a pre-tax gain of $52 million recognized from the sale of our ZEE Medical business. Operating profit for 2017 and 2016 includes $144 million and $76 million of net cash proceeds representing our share of net settlements of antitrust class action lawsuits.
(3) | Technology Solutions segment operating profit for 2017 includes a pre-tax gain of $3,947 million recognized from the Healthcare Technology Net Asset Exchange, net of transaction and related expenses.
(4) | Technology Solutions segment operating profit for 2017 includes a non-cash pre-tax charge of $290 million for goodwill impairment related to the EIS reporting unit. Operating profit for 2016 includes a pre-tax gain of $51 million recognized from the sale of our nurse triage business.
(5) | In 2016, the Company implemented the Cost Alignment Plan to reduce its operating expenses and recorded pre-tax restructuring charges of $229 million in 2016. Pre-tax charges for 2016 were recorded as follows: $161 million, $51 million and $17 million within our Distribution Solutions segment, Technology Solutions segment and Corporate.
(6) | Amounts primarily include amortization of acquired intangible assets purchased in connection with business acquisitions, capitalized software held for sale and capitalized software for internal use.
(7) | Long-lived assets consist of property, plant and equipment.
(8) | Net revenues were attributed to geographic areas based on the customers’ shipment locations.
Segment assets and property, plant and equipment, net by geographic areas were as follows:
| March 31,
(In millions) | 2017 |  | 2016
Segment assets |  |  |
Distribution Solutions | $ | 52,322 |  |  | $ | 47,088 |
Technology Solutions | 4,995 |  |  | 3,072 |
Corporate | 3,652 |  |  | 6,363 |
Total | $ | 60,969 |  |  | $ | 56,523 |
Property, plant and equipment, net |  |  |  |  |
United States | $ | 1,383 |  |  | $ | 1,500 |
Foreign | 909 |  |  | 778 |
Total | $ | 2,292 |  |  | $ | 2,278 |
Assets by operating segment are not reviewed by management for purpose of assessing performance or allocating resources.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration